Rational design of complex formation between plasminogen activator inhibitor-1 and its target proteinases

被引:16
作者
Aertgeerts, K
DeRanter, CJ
Booth, NA
Declerck, PJ
机构
[1] UNIV ABERDEEN,DEPT MOL & CELL BIOL,ABERDEEN AB25 2ZD,SCOTLAND
[2] CATHOLIC UNIV LEUVEN,FAC PHARMACEUT SCI,LAB PHARMACEUT BIOL & PHYTOPHARMACOL,B-3000 LOUVAIN,BELGIUM
关键词
D O I
10.1006/jsbi.1997.3860
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Considerable progress in understanding the mechanism of inhibition of proteinases by serpins has been obtained from different biochemical studies. These studies reveal that stable serpin/proteinase complex formation involves insertion of the reactive-site loop of the serpin and occurs at the acyI-enzyme stage, Even though no three-dimensional structure of a serpin/proteinase complex is resolved, structural information is available on some of the individual compounds. Molecular modeling techniques combined with recently acquired biochemical/biophysical data were used to provide insight into the stable complex formation between plasminogen activator inhibitor-1 (PAI-1) and the target proteinases: tissue-type plasminogen activator, urokinase-type plasminogen activator, and thrombin., This study reveals that PAI-1 initially interacts with its target proteinase when its reactive-site loop is solvent exposed and thereby accessible for the proteinase. Stable complex formation, however, involves the insertion of the reactive-site loop up to P7 and results in a tight binding geometry between PAI-1 and its target proteinase. The influence of different biologically relevant molecules on PAI-1/proteinase complex formation and the differences in inhibition rate constants observed for the different proteinases can be explained from these models. (C) 1997 Academic Press.
引用
收藏
页码:236 / 242
页数:7
相关论文
共 50 条
  • [1] MECHANISMS CONTRIBUTING TO THE CONFORMATIONAL AND FUNCTIONAL FLEXIBILITY OF PLASMINOGEN-ACTIVATOR INHIBITOR-1
    AERTGEERTS, K
    DEBONDT, HL
    DERANTER, CJ
    DECLERCK, PJ
    [J]. NATURE STRUCTURAL BIOLOGY, 1995, 2 (10): : 891 - 897
  • [2] Biochemical and biophysical studies of reactive center cleaved plasminogen activator inhibitor type 1 - The distance between P3 and P1' determined by donor-donor fluorescence energy transfer
    Aleshkov, SB
    Fa, M
    Karolin, J
    Strandberg, L
    Johansson, LBA
    Wilczynska, M
    Ny, T
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (35) : 21231 - 21238
  • [3] CRYSTAL-STRUCTURE OF CLEAVED HUMAN ALPHA-1-ANTICHYMOTRYPSIN AT 2.7-A RESOLUTION AND ITS COMPARISON WITH OTHER SERPINS
    BAUMANN, U
    HUBER, R
    BODE, W
    GROSSE, D
    LESJAK, M
    LAURELL, CB
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 1991, 218 (03) : 595 - 606
  • [4] BJORK I, 1993, BIOCHEMISTRY-US, V32, P6501
  • [5] THE REFINED 1.9 A CRYSTAL-STRUCTURE OF HUMAN ALPHA-THROMBIN - INTERACTION WITH D-PHE-PRO-ARG CHLOROMETHYLKETONE AND SIGNIFICANCE OF THE TYR-PRO-PRO-TRP INSERTION SEGMENT
    BODE, W
    MAYR, I
    BAUMANN, U
    HUBER, R
    STONE, SR
    HOFSTEENGE, J
    [J]. EMBO JOURNAL, 1989, 8 (11) : 3467 - 3475
  • [6] NATURAL PROTEIN PROTEINASE-INHIBITORS AND THEIR INTERACTION WITH PROTEINASES
    BODE, W
    HUBER, R
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1992, 204 (02): : 433 - 451
  • [7] BIOLOGICAL IMPLICATIONS OF A 3-ANGSTROM STRUCTURE OF DIMERIC ANTITHROMBIN
    CARRELL, RW
    STEIN, PE
    WARDELL, MR
    FERMI, G
    [J]. STRUCTURE, 1994, 2 (04) : 257 - 270
  • [8] STRUCTURE AND ENERGETICS OF LIGAND-BINDING TO PROTEINS - ESCHERICHIA-COLI DIHYDROFOLATE REDUCTASE TRIMETHOPRIM, A DRUG-RECEPTOR SYSTEM
    DAUBEROSGUTHORPE, P
    ROBERTS, VA
    OSGUTHORPE, DJ
    WOLFF, J
    GENEST, M
    HAGLER, AT
    [J]. PROTEINS-STRUCTURE FUNCTION AND GENETICS, 1988, 4 (01): : 31 - 47
  • [9] DECLERCK PJ, 1988, J BIOL CHEM, V263, P15454
  • [10] EHRLICH HJ, 1992, J BIOL CHEM, V267, P11606